Related references
Note: Only part of the references are listed.A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines
Hanze Hu et al.
ADVANCED SCIENCE (2021)
Coordination and Redox Dual-Responsive Mesoporous Organosilica Nanoparticles Amplify Immunogenic Cell Death for Cancer Chemoimmunotherapy
Fan Zhang et al.
SMALL (2021)
Review of a new bone tumor therapy strategy based on bifunctional biomaterials
Jinfeng Liao et al.
BONE RESEARCH (2021)
Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer
Connie Kang et al.
DRUGS (2020)
Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind, placebo-controlled clinical trial
Tatul Saghatelyan et al.
PHYTOMEDICINE (2020)
Curcumin effect on cancer cells' multidrug resistance: An update
Saeedeh Keyvani-Ghamsari et al.
PHYTOTHERAPY RESEARCH (2020)
Curcumin downregulates thePI3K-AKT-mTORpathway and inhibits growth and progression in head and neck cancer cells
Gabriel Alvares Borges et al.
PHYTOTHERAPY RESEARCH (2020)
Co-delivery of paclitaxel and curcumin by biodegradable polymeric nanoparticles for breast cancer chemotherapy
Kang Xiong et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Biomimetic Diselenide-Bridged Mesoporous Organosilica Nanoparticles as an X-ray-Responsive Biodegradable Carrier for Chemo-Immunotherapy
Dan Shao et al.
ADVANCED MATERIALS (2020)
Triple-negative breast cancer molecular subtyping and treatment progress
Li Yin et al.
BREAST CANCER RESEARCH (2020)
pH and redox dual responsive carrier-free anticancer drug nanoparticles for targeted delivery and synergistic therapy
Mengjiao Zhou et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death
Ping Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway
Morena Zusso et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Curcumin Combination Chemotherapy: The Implication and Efficacy in Cancer
Bee Ling Tan et al.
MOLECULES (2019)
Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells
Faezeh Ghasemi et al.
PATHOLOGY RESEARCH AND PRACTICE (2019)
Green synthesis of carrier-free curcumin nanodrugs for light-activated breast cancer photodynamic therapy
Madi Sun et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
Targeted Therapies for Triple-Negative Breast Cancer
Tomas G. Lyons
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)
Carrier-free nanodrug: A novel strategy of cancer diagnosis and synergistic therapy
Ming-Yue Yang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Paclitaxel's Mechanistic and Clinical Effects on Breast Cancer
Tala M. Abu Samaan et al.
BIOMOLECULES (2019)
Curcumin as an anti-inflammatory agent: Implications to radiotherapy and chemotherapy
Bagher Farhood et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments
Panchanan Maiti et al.
PLOS ONE (2019)
Graphene-Nanoparticle-Based Self-Healing Hydrogel in Preventing Postoperative Recurrence of Breast Cancer
Qiwen Li et al.
ACS BIOMATERIALS SCIENCE & ENGINEERING (2019)
Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles
Chinmay G. Hiremath et al.
PROGRESS IN BIOMATERIALS (2019)
Targeting Cancer Stem Cells for Chemoprevention of Pancreatic Cancer
Dharmalingam Subramaniam et al.
CURRENT MEDICINAL CHEMISTRY (2018)
The versatile role of curcumin in cancer prevention and treatment: A focus on PI3K/AKT pathway
Leila Hamzehzadeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Anti-angiogenic and anti-inflammatory effects of long-circulating liposomes co-encapsulating curcumin and doxorubicin on C26 murine colon cancer cells
Alina Sesarman et al.
PHARMACOLOGICAL REPORTS (2018)
NIR-Activated Polydopamine-Coated Carrier-Free Nanobomb for In Situ On-Demand Drug Release
Minghui Li et al.
ADVANCED SCIENCE (2018)
Curcumin and paclitaxel induce cell death in breast cancer cell lines
Gloria M. Calaf et al.
ONCOLOGY REPORTS (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Gram-scale production of carrier-free fluorescent berberine microrods for selective liver cancer therapy
Xiao Zheng et al.
BIOFACTORS (2018)
A multifunctional lipid nanoparticle for co-delivery of paclitaxel and curcumin for targeted delivery and enhanced cytotoxicity in multidrug resistant breast cancer cells
Jong-Suep Baek et al.
ONCOTARGET (2017)
Breast Cancer: Multiple Subtypes within a Tumor?
Syn Kok Yeo et al.
TRENDS IN CANCER (2017)
Awareness and current knowledge of breast cancer
Muhammad Akram et al.
BIOLOGICAL RESEARCH (2017)
Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression
Kazuhiro Yoshida et al.
CARCINOGENESIS (2017)
An overview of triple-negative breast cancer
Pankaj Kumar et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)
Clinical Diagnosis and Management of Breast Cancer
Elizabeth S. McDonald et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Share Paper
